Navigation Links
A world without nano? Soon hard to imagine
Date:5/27/2011

e medication increases about 100-fold while side-effects drop dramatically," said Hunziker. Obviously therapeutic nanomaterials must not harm the patient. "At this moment I would rather not have carbon nanotubes in my body, for example," he commented, adding that quite simply, too little was known about the effects they might have on the human organism.

When only a little data is known in such cases, then unease spreads and the public quickly develop reservations. Surveys show that a large fraction of the public knows little or nothing about nanotechnology. "This is exactly the reason why it is incredibly important for researchers to actively encourage discussions about nanotechnology in society generally," as Thomas Borer, the former Swiss ambassador to Germany and CEO of swiss authentication research and development AG, reminded the audience. After all, he added, it is the general public which in the end determines whether or not a new technology is accepted.

The public's fears need to be taken seriously

In Switzerland a positive but critical attitude towards nanotechnology reigns, according to Mauro Dell'Ambrogio, the Secretary of State for Education and Research. Even its critics do not dispute the fact that nanotechnology offers solutions to problems in medicine and environmental protection. But the public's fears should also be taken seriously, and in this context both in Switzerland and in Europe various initiatives are currently in progress where representatives from science and industry, together with consumer and environmental protection organizations, are drafting safety schedules covering the use of various synthetic nanomaterials. This creates a basis which allows industry or the regulatory authorities to make informed decisions on risk reducing measures, when necessary.

Wolf-Michael Catenhusen, the head of the German Federal Environmental Ministry's NanoCommission, was of the opinion that right from the start
'/>"/>

Contact: Dr. Pierangelo Groening
pierangelo.groening@empa.ch
Swiss Federal Laboratories for Materials Science and Technology (EMPA)
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinsons Disease at International Neuromodulation Society 10th World Congress
2. Dyadic to Present at the World Congress on Industrial Biotechnology & Bioprocessing
3. ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells & Regenerative Medicine Congress in London
4. Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing
5. Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World
6. GenomeQuest to Lead Biomarker World Congress Panel on Applying Whole Genome Sequencing to Developing Companion Diagnostics
7. KellBenx Secures Worldwide Agreement With Cedars-Sinai Medical Center for Biomarker Technology to Predict Premature Births
8. CSL Behring Marks World Hemophilia Day by Announcing the Winners of the CSL Behring - Prof. Heimburger Award 2011
9. Organogenesis, Life Sciences Center Break Ground on Worlds Largest Automated Living Cell Manufacturing Plant
10. EMC Isilon Customers Discuss the Big Data Opportunity in Life Sciences at Bio-IT World Conference 2011
11. The worlds smallest wedding rings
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A world without nano? Soon hard to imagine
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/27/2015)... RI (PRWEB) March 27, 2015 Earlier ... for the promotion of hair regrowth in adult men ... classifications I-II or Norwood Hamilton classifications of IIa-V and ... an industry plagued by products that over-promise and under-deliver, ... Capillus272Pro™, renewing faith and confidence among more than 80 ...
(Date:3/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... in accordance with Securities and Exchange Commission rule 10b5-1. ... Corporation, is a minority owner of this entity that ... Herbert does not have control of this entity, but ... for a portion of the shares owned by that ...
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2Neogen CEO adopts 10b5-1 Trading Plan 2
... Leonhardt,s Launchpads ( www.leonhardtslaunchpads.com ), at the ... Center ( www.uncm.edu/STIC.php ), 2330 Circadian Way, Santa ... Grand Opening on Tuesday, November 9th from 3pm ... incubator for startup businesses and high-potential entrepreneurs in ...
... Inc. Prices $50 Million Public Offering ... ... lpUnit=,PRN,; --> ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... Davis Phinney Foundation ( http://www.davisphinneyfoundation.org ), a non-profit foundation ... help people to live well with Parkinson,s disease, today ... Exercise and Parkinson,s: Questions and Answers from the Experts ... experts in the fields of physical therapy and exercise ...
Cached Biology Technology:OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 2OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 3OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 4OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 5OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 6OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 8OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 9Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 2Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 3Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 4
(Date:3/10/2015)... 10, 2015 Transforming How We ... "Personalized Medicine in Human Space Flight" by ... Goodwin , Ph.D. was recently featured by Springer Science ... years. Specifically, "Personalized Medicine in Human Space ... published in 2013 and 2014 from Springer in the ...
(Date:3/5/2015)... SAO PAULO , March 5, 2015 In ... with 41 percent of companies already using these solutions and ... of 2015. Of the latter, approximately 25 percent of the ... time. While the majority of companies in the ... is anticipated that the hybrid model will command significant attention ...
(Date:3/2/2015)... March 2, 2015 Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new implementation ... to enable rapid and secure transactions and reliable ... gaming is a turnkey solution providing mouse and ... quickly integrate fingerprint ID solutions into their product ...
Breaking Biology News(10 mins):"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
... risk of acquiring HIV rises during pregnancy, according to ... by researchers at the Johns Hopkins Bloomberg School of ... even after researchers controlled for behavior and other factors ... published in the September 30, 2005, edition of The ...
... trial, a new drug that selectively blocks immune ... kidney transplant rejection as cyclosporine, the standard anti-rejection ... drug, a co-stimulatory blocker called belatacept (LEA29Y), also ... the toxic side effects associated with standard anti-rejection ...
... have tracked down the biological trigger that gives ... bone disorder that can cause blindness and deafness. ... and could lead to new treatments for osteoporosis ... team from Lawrence Livermore and Lawrence Berkeley national ...
Cached Biology News:Pregnant women at higher risk for HIV, Uganda study finds 2New type of rejection blocker protects kidneys after transplant 2New type of rejection blocker protects kidneys after transplant 3New type of rejection blocker protects kidneys after transplant 4Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
TXNL2 Antibody...
Biology Products: